Weyer-Menkhoff Iris, Lötsch Jörn
Institute of Clinical Pharmacology, Goethe-University.
Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP, Frankfurt am Main, Germany.
Clin J Pain. 2019 Apr;35(4):321-327. doi: 10.1097/AJP.0000000000000677.
Transient receptor potential ion channels play a role in thermal hyperalgesia and are among targets of novel analgesics. However, a role of TRPA1 in either heat or cold hyperalgesia is controversial. In this study, changes in thermal sensitivity were assessed following topical application of a specific sensitizer of TRPA1 and compared with the effects of sensitizers of TRPV1 and TRPM8.
Employing a randomized cross-over design, thermal thresholds were assessed in 16 pain-free volunteers before and at 20 minutes after topical application of cinnamaldehyde, capsaicin or menthol stimulating TRPA1, TRPV1, or TRPM8, respectively. Cold or warm detection thresholds and cold or heat pain thresholds were assessed according to the standardized quantitative sensory testing protocol proposed by the German Research Network on Neuropathic Pain.
The effects of different irritants displayed a cluster structure. Hyperalgesia was induced by capsaicin and cinnamaldehyde on heat pain thresholds and by menthol on cold pain thresholds (Cohen d=2.2035, 0.9932, and 1.256, respectively). A second cluster comprised large effects directed toward hyposensitization, such as cold hyposensitization induced by capsaicin and cinnamaldehyde, or small or absent hyposensitizing effects.
The observation that the TRPA1 irritant cinnamaldehyde induced heat hyperalgesia at an effect sizes comparable with that of capsaicin attributes TRPA1 a role in human heat-induced pain. Results suggest the inclusion of heat pain as a major efficacy measure in human experimental studies of the effects of TRPA1 antagonists and the development of TRPA1 antagonists for clinical pain settings involving heat hyperalgesia.
瞬时受体电位离子通道在热痛觉过敏中起作用,是新型镇痛药的靶点之一。然而,TRPA1在热或冷痛觉过敏中的作用存在争议。在本研究中,在局部应用TRPA1特异性敏化剂后评估热敏感性的变化,并与TRPV1和TRPM8敏化剂的作用进行比较。
采用随机交叉设计,在16名无疼痛志愿者局部应用分别刺激TRPA1、TRPV1或TRPM8的肉桂醛、辣椒素或薄荷醇之前和之后20分钟评估热阈值。根据德国神经性疼痛研究网络提出的标准化定量感觉测试方案评估冷或热检测阈值以及冷或热痛阈值。
不同刺激物的作用呈现聚类结构。辣椒素和肉桂醛诱导热痛阈值升高,薄荷醇诱导冷痛阈值升高(Cohen d分别为2.2035、0.9932和1.256)。第二个聚类包括指向感觉减退的大效应,如辣椒素和肉桂醛诱导的冷感觉减退,或小的或不存在的感觉减退效应。
TRPA1刺激物肉桂醛诱导热痛觉过敏,其效应大小与辣椒素相当,这一观察结果表明TRPA1在人类热诱导疼痛中起作用。结果表明,在TRPA1拮抗剂作用的人体实验研究中应将热痛作为主要疗效指标,并开发用于涉及热痛觉过敏的临床疼痛情况的TRPA1拮抗剂。